Aaron Berger MD

Aaron D. Berger, M.D., earned his Bachelor of Science degree from the University of Wisconsin with a major in biochemistry and molecular biology. Dr. Berger attended medical school at the David Geffen School of Medicine at the University of California, Los Angeles, to earn his M.D. He completed his residency in Urology at the NYU Langone Medical Center in New York. Dr. Berger completed a fellowship at the University of California, San Francisco, in Laparoscopy, Endourology, and Robotic Surgery. Dr. Berger serves on the leadership team and is the current Chief Medical Officer and Director of Clinical Research of Associated Urological Specialists (AUS).

Dr. Berger is a nationally recognized expert in the diagnosis and treatment of prostate cancer and leads our Advanced Prostate Cancer Center.  He has extensive experience with prostate cancer biomarkers, genetic testing, daVinci robotic surgery, androgen receptor pathway inhibitors, immunotherapy, and radioligand therapy.  Dr. Berger also has expertise and has conducted multiple clinical trials in the treatment of high-risk and recurrent bladder cancer.  He has extensive experience in the evaluation and treatment of BPH and procedures such as Urolift, Rezum, and Greenlight laser therapy.